In 2014, recommendations for PZU stock were issued by 20 domestic and foreign financial institutions.
Positive recommendations, that is, buy, accumulate and overweight, slightly outweighed the negative ones (about 35% of all recommendations). The median of target prices from therecommendations valid in December 2014 amounted to PLN 495 and was higher by 11.2% compared with the beginning of the year. The maximum target price was PLN 527 and 1.4%% higher, compared to the maximum target price from January 2014.
The biggest impact on the valuation of PZU shares in 2014 had the expectations of analysts concerning the assumptions of the new strategy, the potential increase in PZU’s revenues due to the acquisition of the insurance companies in Poland and the Baltic states, as well as the issues related to the amount of dividends, including the possibility of further payments from the surplus capital.
The biggest impact on the valuation of PZU shares in 2014 had the expectations of analysts concerning the assumptions of the new strategy, the potential increase in PZU’s revenues due to the acquisition of the insurance companies in Poland
and the Baltic states, as well as the issues related to the amount of dividends, including the possibility of further payments from the surplus capital. The following topics were also stressed: topics concerning the expected results of PZU in the medium and long term in the conditions of low interest rates and the effects of the implementation of Solvency II on the capital position and the dividend policy of PZU.
Distribution of target prices from the recommendations issued in 2014
Analysts’ forecasts towards quote of PZU shares in 2015 based on current recommendations at the end of January 2015
Institutions issuing recommendations for PZU shares in 2014
|Deutsche Bank||Marcin Jabłczyński||+48 22 579 87 firstname.lastname@example.org|
|Dom Maklerski mBanku S.A.||Michał Konarski||+48 22 697 47 email@example.com|
|DM BH (Citi)||Andrzej Powierża||+48 22 690 35 firstname.lastname@example.org|
|Espirito Santo Investment Bank||Kamil Stolarski||+48 22 347 40 email@example.com|
|Ipopema||Iza Rokicka||+48 22 236 92 firstname.lastname@example.org|
|ING||Piotr Palenik||+48 22 820 50 20|
|PKO Dom Maklerski||Jaromir Szortyka||+48 22 580 39 email@example.com|
|Trigon DM||Hanna Kędziorafirstname.lastname@example.org|
|Uni Credit||Paweł Kozub (do grudnia 2014 roku)|
|Wood & Company||Marta Jeżewska-Wasilewska||+48 22 222 15 email@example.com|
|Barclays Capital||Ivan Bokhmat||+44 20 7773 firstname.lastname@example.org|
|Credit Suisse||Richard Burden||+44 20 7888 email@example.com|
|ERSTE||Christoph Schultes||+43 5 0100 firstname.lastname@example.org|
|Exane BNP Paribas||Thomas Jacquet||+33 142 99 51 96||thomas.jacquet@exanebnpparibas.|
|Goldman Sachs||Vinit Malhotra||+44 20 7774 email@example.com|
|HSBC||Dhruv Gahlaut||+44 20 7991 6728||Dhruv.firstname.lastname@example.org|
|JP Morgan||Michael Huttner||+44 20 7325 email@example.com|
|Raiffeisen Centrobank||Bernd Maurer||+43 1 51520 firstname.lastname@example.org|
|UBS||Michael Christelis||+27 11 322 email@example.com|
|Societe Generale||Jason Kalamboussis||+44 207 762 firstname.lastname@example.org|